Earlier Intervention Can Decrease Hospitalizations for COVID-19
Drug Topics
OCTOBER 19, 2022
Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.
Wed.Oct 19, 2022
186 
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Increased HPV Knowledge Could Lead to Increased Vaccination Rates
Drug Topics
OCTOBER 19, 2022
Improving vaccination rates for the most common STI in the United States could be as simple as increasing knowledge about HPV.
CVS Health supports future of pharmacy through minority scholarship program
Drug Store News
OCTOBER 19, 2022
The scholarships represent a commitment to an inclusive community and promoting diversity of thought, background, perspective and experience to advance pharmacy education and improve patient health.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Therapies Targeting Capsid Proteins Show Promise for HIV-1
Pharmacy Times
OCTOBER 19, 2022
By targeting the viral conical core, these ARTs could disrupt the process of assembly and/or disassembly of the virus and result in its suppression.
Could monkeypox infections have long-term consequences?
STAT
OCTOBER 19, 2022
Since the world began confronting a global outbreak of monkeypox in the spring, the scientific community has had plenty of reasons to rue the fact that for decades this virus has been understudied. Here’s another one: Because of that oversight, doctors treating people who have been infected with monkeypox can’t answer with certainty whether some of them will face any long-term health consequences, referred to as sequelae in the field of medicine.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: To learn lessons from pandemics, don’t listen to big pharma
STAT
OCTOBER 19, 2022
Early in the Covid-19 pandemic, the leaders of wealthy countries pledged to respond with “global solidarity.” But when vaccines to prevent the disease were developed, those same leaders pushed low and middle-income countries to the back of the queue, outbidding poorer countries, as well as COVAX, a worldwide initiative developed to achieve equitable vaccine access, to secure vaccines for themselves.
Study Shows Psoriasis Does Not Increase Heart Attack Risk in Patients with Kidney Disease
Pharmacy Times
OCTOBER 19, 2022
The study confirmed that patients with psoriasis are considered to have an increased risk for both chronic kidney disease and ESRD, because inflammation plays a significant role in those conditions as well as heart disease.
Lilly agrees to acquire gene therapy developer Akouos for $610m
Pharmaceutical Technology
OCTOBER 19, 2022
Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of precision genetic medicine firm Akouos for a total deal value of up to nearly $610m or up to $15.50 for each share in cash. The deal comprises an acquisition value of $12.50 for each share in cash payable at closing along with one non-tradeable contingent value right per share (CVR) of up to another $3 in cash.
FDA Grants Emergency Use Authorization for Novavax Adjuvanted COVID-19 Vaccine as Booster for Adults
Pharmacy Times
OCTOBER 19, 2022
Neutralizing antibodies increased by 34- to 27-fold compared to pre-booster levels when administered at 8 or 11 months post-primary series.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Frontiers Health 2022 – day 1
pharmaphorum
OCTOBER 19, 2022
Frontiers Health 2022 in Milan is LIVE! Opening Day One will be Healthware Group’s CEO and founder Roberto Ascione and WTF Health’s founder and host Jessica DaMassa. The day’s keynote addresses will include ‘The H is for humanity’ by MD of Taliossa Tony Estrella and founder and trustee of Rachel’s House Lynna Chandra, as well as ‘Creative disruption in delivering novel VR solutions in pain: evidence, teamwork, and delivery’ by Christopher Eccleston, professor of medical psychology at the U
Prepare for Impact: How the Right Technology Can Energize the Pharmacy Experience
Pharmacy Times
OCTOBER 19, 2022
More than 90% of independent pharmacy customers want technology to enhance their experience. Is your pharmacy ready?
Black Death may have influenced evolution of genes involved in immune responses, study finds
STAT
OCTOBER 19, 2022
The phrase “Black Death mass burial site” tends to evoke images of haphazard piles of diseased deceased like the “bring out your dead” Monty Python scene. But Hendrik Poinar, anthropology professor at McMaster University, said the East Smithfield graveyard in London, a mass burial site that dates back to the height of the bubonic plague pandemic, is the exact opposite.
Technicians Play Key Roles in Health Systems
Pharmacy Times
OCTOBER 19, 2022
Seventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA authorizes booster shot for Novavax’s Covid-19 vaccine
STAT
OCTOBER 19, 2022
The Food and Drug Administration announced Wednesday that it has authorized a booster shot for Novavax’s Covid-19 vaccine. Unlike the latest boosters from Pfizer-BioNTech and Moderna, which target both the original strain of SARS-CoV-2 and the Omicron BA.4/5 variants, the Novavax booster only targets the original strain. The company announced in late May that it was studying an Omicron-targeting strain, as well as a bivalent booster.
Tip of the Week: Prescribing Medicines Must Be Done With Confidence and Competence
Pharmacy Times
OCTOBER 19, 2022
If pharmacists increasingly take up the prescribing mantle, then they must see to their competence to exercise that authority.
STAT+: Large insurer’s decision to cover some prescription digital therapies may be a milestone for app makers
STAT
OCTOBER 19, 2022
A large commercial insurer’s decision to cover a controversial class of software-based treatments for psychiatric and other conditions could prove to be a landmark moment in the development of these so-called prescription digital therapeutics, which until now had been unable to secure coverage from insurers skeptical that the new technologies are as effective as their makers claim.
New PCR Test May Detect COVID-19, 2 Other Respiratory Viruses With Near 100% Efficacy
Pharmacy Times
OCTOBER 19, 2022
The TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR multiplex assay can differentiate between 3 different viral infections (including COVID-19), making it highly cost-effective.
Opinion: STAT+: How digital health innovators can successfully navigate evolving FDA regulations
STAT
OCTOBER 19, 2022
In the rapidly changing landscape of digital health, innovation has often outpaced regulations , especially for novel technologies and emerging industries. To narrow the gap, the Food and Drug Administration has acknowledged that new regulatory policies and frameworks are necessary. To this end, the FDA has been testing new regulatory paradigms , modernizing submission approaches , updating policies , and urging legislative actions to keep up with new developments.
Top 5 Travel Healthcare Myths
Aureus Medical Group
OCTOBER 19, 2022
Traveling. The word itself has so many stereotypes and misconceptions, especially when it comes to healthcare traveling. I want to bring light to a few of those misconceptions so more people fall in love with traveling. Read on for the top six myths that I believe are most common in the traveling industry. Myth #1: “It’s too hard to travel with kids or family.” Many clinicians travel with partners, children, relatives, pets, and even friends!
STAT+: FDA panel votes that a controversial premature birth medication should be withdrawn
STAT
OCTOBER 19, 2022
After an extraordinary three-day hearing, an expert panel of advisers to the U.S. Food and Drug Administration voted on Wednesday to uphold an effort by the regulator to withdraw a controversial drug for preventing premature births. The 14-to-1 vote came after the agency and Covis Pharma, the manufacturer of the drug, offered highly contrasting views of reams of clinical evidence — which they parsed in excruciating detail — in order to settle the fate of the treatment, known as Mak
How the Digital Patient Experience is Shaping the Future of Pharma
pharmaphorum
OCTOBER 19, 2022
From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitised one – a process which has been massively accelerated by the Covid pandemic and has significant implications for pharma & their patients vs. their customers. Join us on Monday 7 th November at 12:30 GMT / 13:30 CET / 7:30 am EDT as panellists focus on how this new paradigm is shaping both the industry’s omnichannel engagement and the patient care journey, from patient identi
Opinion: What the Makena vote means about accelerated approval, trust, and the FDA
STAT
OCTOBER 19, 2022
On Wednesday, the FDA advisory committee that oversees obstetrics, reproductive, and urologic drugs voted 14-1 that the drug Makena was not effective at reducing the risk of preterm birth, and that it should be removed from the market. We’ve been here before. In 2011, the same year that Makena received accelerated approval from the FDA, I was a member of a similar FDA advisory committee hearing in which we considered withdrawing the breast cancer indication for the drug Avastin.
Every scientific message has a story. Medical communications must adapt to effectively bring these to life.
pharmaphorum
OCTOBER 19, 2022
Medical communications are in a state of transition. Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content. Delivering these materials in the proper format, however, requires a keen understanding of providers’ educational needs, learning science, and creative storytelling.
STAT+: Pharmalittle: Merck KGaA probed by French court for misleading info; former Genentech scientists given prison terms over trade-secret theft
STAT
OCTOBER 19, 2022
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is green apple caramel — a new addition to our pantry.
Indegene Acquires CultHealth, a Full Service, Healthcare Marketing Agency to Elevate Brand Experience
PharmExec
OCTOBER 19, 2022
The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy, market development capabilities, and patient engagement platforms.
Listen: What makes food ‘healthy’ and why we don’t prioritize nutrition
STAT
OCTOBER 19, 2022
After years of deliberation, the FDA recently announced a new set of rules it proposes to regulate claims on food packaging that a product is “healthy.” The most basic rule: the product must actually contain food, not just ingredients. This may seem intuitive, but as professor and nutrition policy expert Marion Nestle points out, the food industry works hard to sell their products.
Lannett sells discontinued generics, inks private label deal for others
Drug Store News
OCTOBER 19, 2022
Lannett's deal call for another pharmaceutical company to purchase and distribute under a private label a limited number of certain other Lannett owned generic drug products.
Amplifying HCP engagement using modular content
pharmaphorum
OCTOBER 19, 2022
Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. As the world moves back to a form of normality after the last couple of years, the way in which we engage with HCPs has changed.
Ayala Pharmaceuticals reports promising data from Desmoid Tumors trial
Outsourcing Pharma
OCTOBER 19, 2022
Updated interim results from Part A the RINGSIDE pivotal Phase 2/3 study of the companyâs AL102 new drug showed consistent early tumor shrinkage with measures deepening over time, plus good tolerability at all doses.
High Levels of Biomarker suPAR May Predict Risk of Heart Failure, Death
Pharmacy Times
OCTOBER 19, 2022
New research suggests that high levels of an immune protein in kidney disease might be able to predict risk of heart failure or death by reflecting the upstream process of stress.
U.S. Senators, industry orgs oppose proposed Kroger-Albertsons merger
Drug Store News
OCTOBER 19, 2022
U.S. Sen. Amy Klobuchar (D-Minn.) and U.S. Sen. Mike Lee (R-Utah) announced they will hold a hearing in November to examine the proposed merger.
Existing and Novel Treatments of Migraine Show Favorable Efficacy
Pharmacy Times
OCTOBER 19, 2022
Case studies highlight recent developments and trends in pharmacologic treatments for migraine.
$38 million will fund rare disease research over four-year period
European Pharmaceutical Review
OCTOBER 19, 2022
The US Food and Drug Administration (FDA) has awarded a total of $38 million in the form of 19 new grants and two new contracts, to facilitate the upcoming four years of clinical trials and regulatory tools for rare diseases. Sandra Retzky, Director of the FDA’s Office of Orphan Products Development (OOPD) explained: “The contracts aim to help inform regulatory decision making and promote diversity, equity and inclusion in clinical research.”.
Let's personalize your content